Good Manufacturing Practice (GMP) is the set of principles and procedures that ensures pharmaceutical products, biologicals and certain foods are consistently produced and controlled to the quality standards appropriate to their intended use. Rather than relying on testing the finished product alone, GMP builds quality into every step of manufacture, so that defects are prevented rather than merely detected.
GMP is sometimes written as cGMP — “current” Good Manufacturing Practice — to emphasise that manufacturers must use systems and technologies that remain up to date rather than frozen at the standard of a previous decade.
Where GMP comes from
GMP is not a single document but a family of regulations and guidelines maintained by regulators and harmonised internationally. In the United States it is enforced by the Food and Drug Administration under the Code of Federal Regulations. In the European Union it is set out in the EudraLex volumes and inspected by national competent authorities. The World Health Organization publishes GMP guidance used widely across lower- and middle-income countries, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) coordinates inspection standards between members. The International Council for Harmonisation (ICH) guidelines — notably Q7 on active pharmaceutical ingredients and the Q8–Q12 quality series — give the framework a common scientific basis across regions.
The core principles of GMP
Although wording differs between jurisdictions, the underlying expectations are consistent:
- Defined, validated processes. Manufacturing methods are documented, reviewed and shown to reliably produce a product meeting its specification.
- Controlled facilities and equipment. Premises are designed to prevent contamination and mix-ups, and equipment is qualified and maintained.
- Qualified personnel. Staff are trained for their roles and responsibilities are clearly assigned.
- Documentation and records. Every batch generates records allowing its full history to be reconstructed — the principle that “if it is not written down, it did not happen”.
- Traceability and recall capability. Materials can be traced through the supply chain, and any batch can be recalled if a defect emerges.
- Quality control and quality assurance. Independent testing and an overarching quality system govern release of product.
Data integrity and the ALCOA principles
Because GMP decisions rest on records, regulators place strong emphasis on data integrity. The widely used ALCOA framework holds that data should be Attributable, Legible, Contemporaneous, Original and Accurate — often extended to ALCOA+ with Complete, Consistent, Enduring and Available. These principles closely mirror the reproducibility and provenance concerns that run through the wider research record, which is why metadata standards and persistent identifiers matter beyond the laboratory bench.
GMP and the research record
GMP sits at the regulated end of a continuum that begins with discovery research. The same instincts that drive GMP — documented methods, validated procedures and auditable records — are what make any study reproducible. Reporting standards for laboratory and pre-clinical work, and disciplined description of methods and materials, carry the spirit of GMP upstream into the published literature. For a standards body, GMP is a useful illustration of how quality is engineered into a process rather than inspected into a product after the fact.
Frequently asked questions
What does GMP stand for?
GMP stands for Good Manufacturing Practice: the quality-assurance system that ensures medicinal and related products are consistently produced and controlled to defined standards throughout manufacture.
What is the difference between GMP and cGMP?
They describe the same concept. The “c” for “current” stresses that manufacturers must keep their systems, technologies and methods up to date rather than relying on practices that were once acceptable but have since been superseded.
Who enforces GMP?
National and regional regulators enforce GMP — the FDA in the United States, national authorities under EudraLex in the EU, and others — supported by international harmonisation through ICH and inspection cooperation through PIC/S and WHO guidance.
How does GMP relate to research reproducibility?
Both depend on documented, validated methods and auditable records. The data-integrity principles formalised in GMP (such as ALCOA) echo the provenance and transparency expectations that make any piece of research reproducible. See our guide to Good Clinical Practice and ICH guidelines and the CASRAI research dictionary.